Abstract
Cell-free particles from the liver fluke Fasciola hepatica contain a highly active serotonin stimulated adenylate cyclase. Serotonin (5-HT) stimulates this enzyme 25 to 30-fold over basal activity to activities of 0.80 ± 0.10 nmoles/min·mg protein. Histamine, dopamine, octopamine, epinephrine, and carbachol failed to activate this adenylate cyclase. The kinetics of activation by 5-HT showed apparent negative cooperativity with a Hill coefficient of 0.7. The lower apparent affinity half-maximal activation by 5-HT occurred at 2.1 ± 0.3 µM. Any substitutions on the 5-HT molecule reduced apparent affinity and degree of activation. Apparent affinity and intrinsic activity of indoleamines decreased with decreasing structural similarity to 5-HT. All indoleamines tested compete for the serotonin receptor. Derivatives of lysergic acid also activate this adenylate cyclase, with very high apparent affinity. D-lysergic acid diethylamide (LSD) was the most potent derivative activating maximally about 25% of 5-HT stimulated activity. Half-maximal activation by D-LSD occurred at 40 nM. Activation by LSD was totally stereospecific, with the L-isomer inactive even at 1 mM. Both D- and L-LSD antagonized 5-HT stimulation, but the L-isomer had a 500-fold decreased affinity. 2-bromo LSD (BOL) competitively antagonized 5-HT activation as shown by Schild analysis. BOL also directly inhibited basal (nonactivated) adenylate cyclase. The direct inhibition and antagonism of 5-HT by BOL both involved a single population of receptor sites with the same inhibition constant. This result suggests that BOL inhibits adenylate cyclase by interacting with the 5-HT site and that BOL has a "negative" efficacy for this receptor. The evidence supports a single class of adenylate cyclase regulated only by serotonin receptors.
- Copyright © 1978 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|